TrialNature communications2021

Peginterferon Lambda-1a for treatment of outpatients with uncomplicated COVID-19: a randomized placebo-controlled trial.

Prasanna Jagannathan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.